Ganoderma lucidum polysaccharide used for treating physical frailty in China

Zeng, P., Chen, Y., Zhang, L. and Xing, M. · Progress in Molecular Biology and Translational Science · 2019

Meta-analysis / review

Abstract

This review covers over 40 years of clinical use of Ganoderma lucidum (lingzhi) polysaccharide in China for neurosis, myopathy and as adjunct cancer-chemotherapy support, summarising its antioxidant, antitumour, immunomodulatory and hypoglycemic mechanisms.

Referenced for these plants

How to cite

Zeng, P., Chen, Y., Zhang, L. and Xing, M (2019) 'Ganoderma lucidum polysaccharide used for treating physical frailty in China', Progress in Molecular Biology and Translational Science, 163, pp. 179-219. doi:10.1016/bs.pmbts.2019.02.009

This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.